{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:37:05Z","timestamp":1790879825160,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002001","name":"Health Services and Delivery Research Programme","doi-asserted-by":"publisher","award":["NIHR HS&DR 14\/46\/19"],"award-info":[{"award-number":["NIHR HS&DR 14\/46\/19"]}],"id":[{"id":"10.13039\/501100002001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40258-022-00745-w","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T17:09:41Z","timestamp":1658509781000},"page":"905-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-1257","authenticated-orcid":false,"given":"Caroline S.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-1612","authenticated-orcid":false,"given":"Mariya","family":"Melnychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-6916","authenticated-orcid":false,"given":"Angus I. G.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7859-1646","authenticated-orcid":false,"given":"Cecilia","family":"Vindrola-Padros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Levermore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Barod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8499-2662","authenticated-orcid":false,"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-7694","authenticated-orcid":false,"given":"John","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-5456","authenticated-orcid":false,"given":"Muntzer M.","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2384-9475","authenticated-orcid":false,"given":"Kathy","family":"Pritchard-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-4433","authenticated-orcid":false,"given":"Maxine","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-2556","authenticated-orcid":false,"given":"David C.","family":"Shackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-3563","authenticated-orcid":false,"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5306-6140","authenticated-orcid":false,"given":"Naomi J.","family":"Fulop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8934","authenticated-orcid":false,"given":"Rachael M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13012-016-0445-z","volume":"11","author":"NJ Fulop","year":"2016","unstructured":"Fulop NJ, Ramsay AI, Perry C, Boaden RJ, McKevitt C, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CD, Morris S. Explaining outcomes in major system change: a qualitative study of implementing centralised acute stroke services in two large metropolitan regions in England. Implement Sci. 2016;11:80.","journal-title":"Implement Sci"},{"issue":"62","key":"745_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/gutjnl-2012-303008","volume":"966","author":"VH Coupland","year":"2013","unstructured":"Coupland VH, Lagergren J, L\u00fcchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce M, M\u00f8ller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004\u20132008. Gut. 2013;966(62):961.","journal-title":"Gut"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/01.ju.0000140257.05714.45","volume":"172","author":"M Nuttall","year":"2004","unstructured":"Nuttall M, van der Meulen J, Phillips N, Sharpin C, Gillatt D, McIntosh G, Emberton M. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol. 2004;172:2145\u201352.","journal-title":"J Urol"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.healthpol.2011.05.015","volume":"104","author":"N Fulop","year":"2012","unstructured":"Fulop N, Walters R, Perri P, Spurgeon P. Implementing changes to hospital services: factors influencing the process and \u2018results\u2019 of reconfiguration. Health Policy. 2012;104:128\u201335.","journal-title":"Health Policy"},{"key":"745_CR5","volume-title":"Healthcare for London: a framework for action","author":"A Darzi","year":"2007","unstructured":"Darzi A. Healthcare for London: a framework for action. 2nd ed. London: NHS London; 2007.","edition":"2"},{"key":"745_CR6","volume":"349","author":"S Morris","year":"2014","unstructured":"Morris S, Hunter RM, Ramsay AIG, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Schwamm LH, Turner SJ, Tyrrell PJ, Wolfe CDA, Fulop NJ. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. BMJ Open. 2014;349: g4757.","journal-title":"BMJ Open"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/STROKEAHA.115.009723","volume":"46","author":"AIG Ramsay","year":"2015","unstructured":"Ramsay AIG, Morris S, Hoffman A, Hunter RM, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CDA, Fulop NJ. Effects of centralizing acute stroke services on stroke care provision in two large metropolitan areas in England. Stroke. 2015;46:2244\u201351.","journal-title":"Stroke"},{"key":"745_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011214","volume":"6","author":"N Bhattarai","year":"2016","unstructured":"Bhattarai N, McMeekin P, Price C, Vale L. Economic evaluations on centralisation of specialised healthcare services: a systematic review of methods. BMJ Open. 2016;6: e011214.","journal-title":"BMJ Open"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1136\/bmj.319.7216.1063","volume":"319","author":"J Posnett","year":"1999","unstructured":"Posnett J. The hospital of the future: is bigger better? Concentration in the provision of secondary care. BMJ. 1999;319:1063\u20135.","journal-title":"BMJ"},{"key":"745_CR10","volume-title":"The reconfiguration of clinical services. What is the evidence?","author":"C Imison","year":"2014","unstructured":"Imison C, Sonola L, Honeyman M, Ross S. The reconfiguration of clinical services. What is the evidence? London: The King\u2019s Fund; 2014."},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13012-014-0168-y","volume":"9","author":"T Hoomans","year":"2014","unstructured":"Hoomans T, Severens JL. Economic evaluation of implementation strategies in health care. Implement Sci. 2014;9:168.","journal-title":"Implement Sci"},{"key":"745_CR12","volume-title":"Chapter 23 of improving patient care: the implementation of change in health care","author":"JL Severens","year":"2020","unstructured":"Severens JL, Hoomans T, Adang E, Wensing M. Economic evaluation of implementation strategies. In: Wensing M, Grol R, Grimshaw J, editors. Chapter 23 of improving patient care: the implementation of change in health care. 3rd ed. Oxford: Wiley; 2020.","edition":"3"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10198-007-0043-8","volume":"8","author":"L Vale","year":"2007","unstructured":"Vale L, Thomas R, MacLennan G, Grimshaw J. Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ. 2007;8:111\u201321.","journal-title":"Eur J Health Econ"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/S1744133118000063","volume":"14","author":"R Meacock","year":"2019","unstructured":"Meacock R. Methods for the economic evaluation of changes to the organisation and delivery of health services: principal challenges and recommendations. Health Econ Policy Law. 2019;14:119\u201334.","journal-title":"Health Econ Policy Law"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1365-2354.2011.01323.x","volume":"21","author":"KM Ke","year":"2012","unstructured":"Ke KM, Hollingworth W, Ness AR. The costs of centralisation: a systematic review of the economic impact of the centralisation of cancer services. Eur J Cancer Care. 2012;21:158\u201368.","journal-title":"Eur J Cancer Care"},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13012-016-0520-5","volume":"11","author":"NJ Fulop","year":"2016","unstructured":"Fulop NJ, Ramsay AIG, Vindrola-Padros C, Aitchison M, Boaden RJ, Brinton V, Clarke CS, Hines J, Hunter RM, Levermore C, Maddineni SB, Melnychuk M, Moore CM, Mughal MM, Perry C, Pritchard-Jones K, Shackley DC, Vickers J, Morris S. Reorganising specialist cancer surgery for the twenty-first century: a mixed methods evaluation (RESPECT-21). Implement Sci. 2016;11:155.","journal-title":"Implement Sci"},{"key":"745_CR17","doi-asserted-by":"crossref","unstructured":"Fulop NF, Ramsay AIG, Vindrola-Padros C, Clarke CS, Hunter RM, Black GB, Wood VJ, Melnychuk M, Perry C, Vallejo-Torres L, Ng P-L, Barod R, Bex A, Boaden R, Bhuiya A, Brinton V, Fahy P, Hines J, Levermore C, Maddineni S, Mughal MM, Pritchard-Jones K, Sandell J, Shackley DC, Tran M and Morris S. Centralisation of specialist cancer surgery services in two areas of England: the RESPECT-21 mixed-methods evaluation. Health Soc Care Deliv Res. 2022 (In press).","DOI":"10.3310\/QFGT2379"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1355819620926553","volume":"26","author":"C Vindrola-Padros","year":"2020","unstructured":"Vindrola-Padros C, Ramsay AI, Perry C, Darley S, Wood VJ, Clarke CS, Hines J, Levermore C, Melnychuk M, Moore CM, Morris S, Mughal MM, Pritchard-Jones K, Shackley D, Fulop NJ. Implementing major system change in specialist cancer surgery: the role of provider networks. J Health Serv Res Policy. 2020;26:4\u201311.","journal-title":"J Health Serv Res Policy"},{"key":"745_CR19","volume-title":"Improving specialist cancer and cardiovascular services in North and East London","author":"NHS England","year":"2014","unstructured":"England NHS. Improving specialist cancer and cardiovascular services in North and East London. West Essex: Business Case; 2014."},{"issue":"6","key":"745_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40258-021-00660-6","volume":"19","author":"CS Clarke","year":"2021","unstructured":"Clarke CS, Vindrola-Padros C, Levermore C, Ramsay AI, Black GB, Pritchard-Jones K, Hines J, Smith G, Bex A, Mughal M, Shackley D, Melnychuk M, Morris S, Fulop NJ, Hunter RM. How to cost the implementation of major system change for economic evaluations: case study using reconfigurations of specialist cancer surgery in part of London, England. Appl Health Econ Health Policy. 2021;19(6):797\u2013810.","journal-title":"Appl Health Econ Health Policy"},{"key":"745_CR21","unstructured":"Melnychuk M, Clarke CS, Hunter RM, Ramsay AI, Vindrola-Padros C, Black GB, Levermore C, Sandell J, Barod R, Bex A, Hines J, Mughal MM, Pritchard-Jones K, Tran MG, Maddineni S, Shackley D, Ng P-L, Fulop NJ, Morris S. Impact of major system change in specialist cancer surgery in London, UK: difference-in-differences analysis. 2022 (Submitted)."},{"key":"745_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ije\/dyz076","volume":"49","author":"KE Henson","year":"2020","unstructured":"Henson KE, Elliss-Brookes L, Coupland VH, Payne E, Vernon S, Rous B, Rashbass J. Data resource profile: national cancer registration dataset in England. Int J Epidemiol. 2020;49:16\u201316h.","journal-title":"Int J Epidemiol"},{"key":"745_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/13558196221082585","author":"GB Black","year":"2022","unstructured":"Black GB, Wood VJ, Ramsay AI, Vindrola-Padros C, Perry C, Clarke CS, Levermore C, Pritchard-Jones K, Bex A, Tran MG, Shackley DC, Hines J, Mughal MM, Fulop NJ. Loss associated with subtractive health service change: the case of specialist cancer centralization in England. J Health Serv Res Policy. 2022. https:\/\/doi.org\/10.1177\/13558196221082585.","journal-title":"J Health Serv Res Policy"},{"key":"745_CR24","doi-asserted-by":"publisher","unstructured":"Herbert A, Wijlaars L, Zylbersztejn A, Cronwell D, Hardelid P. Data resource profile: hospital episode statistics admitted patient care (HES APC). Int J Epidemiol 2017;46(4):1093\u20131093i. https:\/\/doi.org\/10.1093\/ije\/dyx015.","DOI":"10.1093\/ije\/dyx015"},{"issue":"4","key":"745_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40273-014-0247-6","volume":"33","author":"RM Hunter","year":"2015","unstructured":"Hunter RM, Baio G, Butt T, Morris S, Round J, Freemantle N. An educational review of the statistical issues in analysing utility data for cost-utility analysis. Pharmacoeconomics. 2015;33(4):355\u201366.","journal-title":"Pharmacoeconomics"},{"key":"745_CR26","unstructured":"Curtis LA, Burns A. Unit Costs of Health and Social Care 2015. Canterbury, 2015."},{"key":"745_CR27","unstructured":"Curtis LA, Burns A. Unit Costs of Health and Social Care 2018. Canterbury, 2018."},{"key":"745_CR28","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: OUP; 2015.","edition":"4"},{"key":"745_CR29","unstructured":"Public Health England (PHE). Personal communication, CancerStats, PHE; Number of newly diagnosed patients in NCEL and West Essex in 2017; 2019."},{"issue":"6","key":"745_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269192","volume":"17","author":"CS Clarke","year":"2022","unstructured":"Clarke CS, Hunter RM, Gabrio A, Brawley CD, Ingleby FC, Dearnaley DP, Matheson D, Attard G, Rush HL, Jones RJ, Cross W, Parker C, Russell JM, Millman R, Gillessen S, Malik Z, Lester JF, Wylie J, Clarke NW, Parmar MK, Sydes MR, James ND. Cost-utility analysis of adding abiraterone acetate plus prednisone\/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. PLoS ONE. 2022;17(6): e0269192.","journal-title":"PLoS ONE"},{"issue":"8","key":"745_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202796","volume":"13","author":"AJ Sutton","year":"2018","unstructured":"Sutton AJ, Lamont JV, Evans RM, Williamson K, O\u2019Rourke D, Duggan B, Sagoo GS, Reid CN, Ruddock MW. An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer. PLoS ONE. 2018;13(8): e0202796.","journal-title":"PLoS ONE"},{"issue":"9","key":"745_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040284","volume":"4","author":"GS Kulkarni","year":"2007","unstructured":"Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Optimal management of high-risk T1G3 bladder cancer: a decision analysis. PLoS Med. 2007;4(9): e284.","journal-title":"PLoS Med"},{"key":"745_CR33","unstructured":"National Institute for Health and Care Excellence (NICE), Developing NICE guidelines: the manual (PMG20); 2014, updated 2018."},{"key":"745_CR34","unstructured":"National Institute for Health and Care Excellence. Lenvatinib with everolimus for previously treated advanced renal cell carcinoma (NICE Guidance TA498); 2018. [Online]. www.nice.org.uk\/guidance\/ta498."},{"key":"745_CR35","unstructured":"National Institute for Health and Care Excellence. Everolimus for advanced renal cell carcinoma after previous treatment (NICE Guidance TA432); 2017. [Online]. www.nice.org.uk\/guidance\/ta432."},{"key":"745_CR36","unstructured":"National Institute for Health and Care Excellence. Nivolumab for previously treated advanced renal cell carcinoma (NICE Guidance TA417); 2016. [Online]. www.nice.org.uk\/guidance\/ta417."},{"key":"745_CR37","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1245\/s10434-013-3103-6","volume":"20","author":"L Lee","year":"2013","unstructured":"Lee L, Sudarshan M, Li C, Latimer E, Fried GM, Mulder DS, Feldman LS, Ferri LE. Cost-effectiveness of minimally invasive versus open esophagectomy for esophageal cancer. Ann Surg Oncol. 2013;20:3732\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"745_CR38","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.athoracsur.2006.11.061","volume":"83","author":"AJ Graham","year":"2007","unstructured":"Graham AJ, Shrive FM, Ghali WA, Manns BJ, Grondin SC, Finley RJ, Clifton J. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg. 2007;83(4):1257\u201364.","journal-title":"Ann Thorac Surg"},{"key":"745_CR39","unstructured":"National Institute for Health and Care Excellence. Oesophago-gastric cancer: assessment and management in adults (NICE Guideline NG83); 2018. [Online]. www.nice.org.uk\/guidance\/ng83."},{"key":"745_CR40","unstructured":"National Institute for Health and Care Excellence. Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours (NICE Guideline TA488); 2017. [Online]. www.nice.org.uk\/guidance\/ta488."},{"key":"745_CR41","unstructured":"National Institute for Health and Care Excellence. Trastuzumab for the treatment of HER2-positive metastatic gastric cancer\u00a0(NICE Guideline TA208); 2010. [Online]. www.nice.org.uk\/guidance\/ta208."},{"key":"745_CR42","unstructured":"National Institute for Health and Care Excellence. Sunitinib for the treatment of gastrointestinal stromal tumours\u00a0(NICE Guideline TA179); 2009. [Online]. www.nice.org.uk\/guidance\/ta179."},{"key":"745_CR43","unstructured":"National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal\u2019 2013. [Online]. http:\/\/publications.nice.org.uk\/pmg9. Accessed Jan 2015."},{"key":"745_CR44","unstructured":"Center for the Evaluation of Value and Risk in Health. The Cost-Effectiveness Analysis Registry,\u201d Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA, [Online]. www.cearegistry.org. Accessed 2019."},{"key":"745_CR45","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modelling valuations for EuroQol health states. Med Care. 1997;35:1095\u2013108.","journal-title":"Med Care"},{"issue":"5","key":"745_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechter H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"745_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware","year":"1996","unstructured":"Ware J, Kosinski M, Keller S. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"key":"745_CR48","unstructured":"Clarke CS. Personal communication based on STAMPEDE patient-level data in control arm (recruited 2011\u20132014); 2020."},{"key":"745_CR49","unstructured":"National Institute for Health and Care Excellence (NICE). Bladder cancer: diagnosis and management: NICE guideline NG2; 2015. [Online]. www.nice.org.uk\/guidance\/ng83. Accessed Dec 2020."},{"issue":"4","key":"745_CR50","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/j.clgc.2019.12.004","volume":"18","author":"E Cox","year":"2019","unstructured":"Cox E, Saramago P, Kelly J, Porta N, Hall E, Tan WS, Sculpher M, Soares M. Effects of bladder cancer on UK healthcare costs and patient health-related quality of life: evidence from the BOXIT trial. Clin Genitourin Cancer. 2019;18(4):e418-442.","journal-title":"Clin Genitourin Cancer"},{"key":"745_CR51","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.euf.2017.03.010","volume":"4","author":"C Camp","year":"2018","unstructured":"Camp C, O\u2019Hara J, Hughes D, Adshead J. Short-term outcomes and costs following partial nephrectomy in England: a population-based study. Eur Urol Focus. 2018;4:579\u201385.","journal-title":"Eur Urol Focus"},{"key":"745_CR52","doi-asserted-by":"publisher","DOI":"10.3310\/hta17390","author":"IT Russell","year":"2013","unstructured":"Russell IT, Edwards RT, Gliddon AE, Ingledew DK, Russell D, Whitaker R, Yeo ST, Attwood SE, Barr H, Nanthakumaran S, Park KG. Cancer of Oesophagus or Gastricus\u2014new Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial. Health Technol Assess. 2013. https:\/\/doi.org\/10.3310\/hta17390.","journal-title":"Health Technol Assess"},{"issue":"10","key":"745_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0269216315595203","volume":"29","author":"J Round","year":"2015","unstructured":"Round J, Jones L, Morris S. Estimating the cost of caring for people with cancer at the end of life: a modelling study. Palliat Med. 2015;29(10):899\u2013907.","journal-title":"Palliat Med"},{"key":"745_CR54","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006."},{"issue":"14","key":"745_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19140","volume":"19","author":"K Claxton","year":"2015","unstructured":"Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Methods for the estimation of the NICE cost effectiveness threshold. Health Technol Assess. 2015;19(14):1\u2013503.","journal-title":"Health Technol Assess"},{"key":"745_CR56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40273-020-00907-5","volume":"38","author":"M Franklin","year":"2020","unstructured":"Franklin M, Lomas J, Richardson G. Conducting value for money analyses for non-randomised interventional studies including service evaluations: an educational review with recommendations. Pharmacoeconomics. 2020;38:665\u201381.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"745_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2008.12.008","volume":"113","author":"JP Greving","year":"2009","unstructured":"Greving JP, Vernooij F, Heintz AP, van der Graaf Y, Buskens E. Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis. Gynecol Oncol. 2009;113(1):68\u201374.","journal-title":"Gynecol Oncol"},{"key":"745_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-018-03022-w","volume":"141","author":"C Lopez Ramos","year":"2019","unstructured":"Lopez Ramos C, Brandel MG, Steinberg JA, Wali AR, Rennert RC, Santiago-Dieppa DR, Sarkar RR, Pannell JS, Murphy JD, Khalessi AA. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma. J Neuro-Oncol. 2019;141:159\u201366.","journal-title":"J Neuro-Oncol"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-022-00745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-022-00745-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-022-00745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T21:56:10Z","timestamp":1700862970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-022-00745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s40258-022-00745-w","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"28 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper presents independent research commissioned by the National Institute for Health and Care Research (NIHR) Health Services and Delivery Research Programme, funded by the Department of Health and Social Care (study reference 14\/46\/19). NJF is an NIHR Senior Investigator. CVP and NJF are in part supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart\u2019s Health NHS Trust. KPJ was funded by UCLPartners Academic Health Science Network as Cancer Programme Director and as Chief Medical Officer of London Cancer from 2011 to 2016 when the latter funding reverted to the National Cancer Vanguard programme held locally by the University College London Hospitals (UCLH) Cancer Collaborative on behalf of all acute provider trusts in North Central and North East London and West Essex. London Cancer received funding from National Health Service (NHS) England (London Region). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Besides the funding received by authors\u2019 institutions from the NIHR for this work as mentioned in the \u2018Funding\u2019 section, KPJ was Chief Medical Officer for London Cancer during the period of the changes described in this paper. MT has received payment or honoraria for teaching and educational events from Boston Scientific Corporation, grants from the NIHR paid to her institution, and payment for expert testimony as an external clinical advisor from the Parliamentary ombudsman for health services, and is a Trustee of Kidney Cancer UK and Governor of Royal Free London NHS Foundation Trust. DCS has received grants or contracts from CRUK for the ACED project, regarding research into early detection of cancer (A27859), and held a director role in the Greater Manchester Cancer Alliance (a NHS England cancer alliance). NJF has received grants or contracts from The Health Foundation and THIS Institute paid to her institution, and holds the role of Non-Executive Director, Whittington Health NHS Trust, and is a Trustee of Health Services Research UK. AIGR is also a Trustee of Health Services Research UK. All other authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets generated and analysed during the current study are not shareable due to confidentiality.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was reviewed and approved by the Proportionate Review Subcommittee of the NRES Committee Yorkshire and the Humber\u2014Leeds (reference number 15\/YH\/0359).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"CSC led the analysis, design and interpretation and wrote the first draft of the paper; MMe, AIGR, CVP, DCS, SM, NJF and RMH conceived of the initial study design; MMe, SM and RMH assisted in the analysis; AIGR, CVP, SM, NJF and RMH interpreted the results; RB, AB, JH, MMu, KPJ and MT provided clinical and health services input; CL provided health services input; NJF led the overall RESPECT-21 mixed methods programme of research. All authors contributed to the drafting of the paper and approved the final version.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable as this analysis used anonymised routinely collected data.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication (from patients\/participants)"}},{"value":"Analysis code can be made available on request to the authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}